1.Effect of Epalrestat on Heart Rate Variability in Patients with Diabetic Asymptomatic Myocardial Ischemia
China Pharmacist 2015;(1):110-112
Objective:To observe the effect of epalrestat on the heart rate variability in diabetes patients with silent myocardial is-chemia. Methods:Totally 60 patients were randomly divided into the control group and the treatment group with 30 cases in each. The two groups were given insulin or other routine drugs to keep blood sugar under control, ARB or ACEI and CCB to bring high blood pres-sure down, and statins to regulate lipid and anti-platelet aggregation, and both groups were without the use of beta blockers. The treat-ment group was given epalrestat 50mg three times a day for 4 weeks additionally. The indices of FPG, 2hPG, HbA1c, SBP, DBP, T-CHOL, TG, HDL-C, LDL-C and heart rate variability were observed after the treatment. Results: Compared with those before the treatment, the values of FPG, 2HPG, HbA1C, SBP, DBP, T-CHOL and LDL-c were decreased after the treatment in the two groups, and the differences were statistically significant (P <0.05), while the differences between the two groups were not obvious(P >0. 05). After the treatment, SDNN, SDANN, SDNNI, RMSSD, PNN50 and Mean HR in the treatment group were obviously im-proved, which were better than those in the control group (P<0.05). The adverse reactions in the two groups were similar (P<0. 05). Conclusion:Epalrestat can significantly improve HRV-related indicators in the diabetes patients with silent myocardial ischemi-a, which can reduce the risk of sudden death without significant adverse reactions in the combination with other drugs.
2.Study of recurrence in breast cancer by different methods
Xialing SHENG ; Xiao XIAO ; Sue ZHONG ; Jinfeng ZENG ; Yuting HUANG
Chinese Journal of Primary Medicine and Pharmacy 2005;0(02):-
Objective To study the influence factor of recurrence in breast cancer.Methods The grouping treatment and tumor by stages,tumor transfer were observed in 105 cases with primary breast cancer.Results Among 105 patients,the inside of 2 years relapse was 47.6%(50/105);Tumor Ⅱ period recurrence rate was 40.0%(10/25),Ⅲ period recurrence rate was 28.0%(7/25);Among 105 cases,the distant place transfer to recurrence rate was 31.4%(33/105);Among 105 patients for surgical operation,its relapsing rate was 40.0%,but in 25 cases after operation putting radiation treatment,relapse rate was 16.0%;The part recurrence rate totally was 58.0%(61/105),among them the chest wall recurrence rate was 13.3%(14/105);The supraclavilar lymphonodes transfer was 20.9%(22/105),the axlla lymphnides transfer was 23.8%(25/105);The distant place transfer was 31.4%(33/105).Conclusion The recurrence rate of association treatment obviously is lower than that pure surgical operation,the relapsing of tumor with tumor by stages and transfer relevanted.
3.Efficiency of intra-arterial neoadjuvant chemotherapy in patients with cervical cancer
Xialing SHENG ; Xiao XIAO ; Sue ZHONG ; Jinfeng ZENG ; Yuting HUANG
Chinese Journal of Primary Medicine and Pharmacy 2006;0(03):-
Objective To explore the effrciency of intra-arterial neoadjuvant chemotherapy before radical excision in patients with cervical cancer.Methods 50 cases with cervical cancer were enrolled into the study and were treated with a 2~3 course of intra-arterial neoadjuvant chemotherapy immediately after the pathological diagnosis.The regime included Then radical excision was performed in those who were good for the operation.Results Complete recovery(CR) was acquired in 12 patients and partial recovery(PR) in 26 patients.The total response rate was 76.0 %.The tumor size reduced significantly(P
4.Antagonistic effect of astragaloside on immune response of regulatory T cells mediated by high mobility group box-1 protein in rats
Jinfeng LI ; Yongming YAO ; Lifeng HUANG ; Shuwen ZHANG ; Zhenyu ZHANG ; Zhiyong SHENG
Chinese Journal of Trauma 2013;29(10):919-923
Objective To investigate the antagonistic effect of different doses of astragaloside Ⅳ (AST Ⅳ) on immune function of regulatory T (Treg) cells mediated by high mobility group box-1 protein (HMGB1) in rats and the mechanism by which AST Ⅳ exerts its influence.Methods CD4 + CD25 +Treg cells isolated from the spleens of clean-grade BALB/c mice were seeded on 72-well culture plate.Cells were divided into four groups (18 wells per group) according to the random number table,i.e.normal control group (cells were cultured merely),HMGB1 (1 μg/ml) group,HMGB1 (1 μg/ml) + AST Ⅳ (50 μg/ml) group,and HMGB1 (1 μg/ml)+AST Ⅳ (100 μg/ml) group.Each group consisted of three subgroups (6 wells per group),from which the Treg cells were collected at post-stimulation hours 24,48 and 72 respectively.Foxp3 intracellular protein and mRAN expressions were detected by flow cytometry and quantitative fluorescent PCR.Contents of IL-10 and TGF-β released into the supernatants were determined by ELISA method.Results As compared with the control group,Foxp3 intracellular protein and mRAN expressions in the Treg cells were decreased at 24 hours to 72 hours after HMGB1 stimulation (P < 0.01),with particular reduction at 72 hours.Additionally,changes of IL-10 and TGF-βin the supernatants presented the same trends with Foxp3.Foxp3 protein and mRAN expressions in AST Ⅳ group were markedly higher than that in HMGB1 group at 24-72 hours (P < 0.05) and the expressions in AST Ⅳ(100 μg/ml) group were much more significant than that in AST Ⅳ (50 μg/ml) group (P < 0.05).While contents of IL-10 and TGF-β in supernatants revealed the same trend with Fox3 as well.Conclusions AST Ⅳ antagonizes the impact of HMGB1 on the activity of the Treg cells in a dose-dependent manner in vitro.It is suggested that AST Ⅳ has a strong inhibitory effect on HMGB1-mediated inflammatory response.
5.Intervention effects of cognitive behavior therapy on negative emotion, quality of life and quality of sleep in patients with brain neoplasm: a Meta-analysis
Jinfeng ZHU ; Lu CHEN ; Lixinbei SHENG ; Fang WANG ; Xiaoyan BAI
Chinese Journal of Modern Nursing 2021;27(21):2917-2924
Objective:To evaluate intervention effects of cognitive behavioral therapy on reducing negative emotions in patients with intracranial tumors and improving their quality of life and sleep quality by using Meta-analysis.Methods:Cochrane Library, Web of Science, Embase, PubMed, CNKI, VIP Chinese Journal Database, China Biology Medicine disc and Wanfang Database were searched for randomized controlled studies on interventions of cognitive behavioral therapy in anxiety, depression, quality of life and sleep quality of patients with brain neoplasm. After screening, extracting and evaluating data, the two researchers performed a Meta-analysis using RevMan 5.3 statistical software.Results:A total of 22 literatures met the inclusion criteria, with a total sample size of 1 702 cases. The analysis of the results showed that cognitive behavioral therapy could help reduce the anxiety level of patients with brain neoplasm [ SMD=-1.13, 95% CI: (-1.31, -0.96) , P<0.01], depression level [ SMD=-1.09, 95% CI: (-1.27, -0.92) , P<0.01], which could improve quality of life [ SMD=0.29, 95% CI: (0.06, 0.51) , P=0.01] and sleep quality [ MD=-0.32, 95% CI: (-0.36, -0.28) , P<0.01] of patients and improve satisfaction of patients with nursing [ MD=-8.25, 95% CI: (3.54, 19.24) , P<0.01]. Conclusions:Existing evidence shows that the use of cognitive behavioral therapy can help improve the negative emotions of patients with brain neoplasm, improve their quality of life and sleep quality and improve their satisfaction with nursing.
6.Terpenoids of Heteroplexis micocephala and their bioactivities.
Xiaona FAN ; Sheng LIN ; Chenggen ZHU ; Jinfeng HU ; Yang LIU ; Xiaoguang CHEN ; Naihong CHEN ; Wenjie WANG ; Jiangong SHI
China Journal of Chinese Materia Medica 2010;35(3):315-322
OBJECTIVETo investigate the chemical constituents of Heteroplexis nicocephala.
METHODThe constituents were isolated by using a combination of various chromatographic techniques including column chromatography over silica gel, Pharmadex LH-20, and C-18, as well as reversed-phase HPLC. Structures of the isolates were identified by spectroscopic data analysis. In vitro cytotoxic, neuroprotective, and anti-inflammatory activities were screened by using cell-based models.
RESULTSeventeen terpenoids were isolated. The structures were identified as two monoterpenoids: (-)-bomyl ferulate(1) and loliolide(2). Seven sesquiterpenoids: 1beta-hydroxy-alpha-cyperone(3) , alpha-rotunol(4), 10alpha-hydroxycadin-4-en-15-al (5), 1-epi-10beta-hydroxycadin-4-en-15-al(6), 10alpha-hydroxyisodauc-3-en-15-al(7), germacrene B(8), and mandassidione(9). Five diterpenoids: 12-epi-bacchotricuneatin A(10), 1-hydroxy-12-epi-bacchotricuneatin A(11), cleroinermin(12), desoxyarticulin(13), and anhydroolearin(14). And three triterpenoids: friedelin (15), ursolic acid(16), and obtusalin(17). In the in vitro assays, 1 showed selective cytotoxic activity against BGC-823, with an IC50 value of 8.00 x 10(-5) mol x L(-1). At a concentration of 1 x 10(-5) mol x L(-1), 12 showed neuroprotective activity against MPP+ induced PC12-syn cell damage, with a relative cell proliferation rate of 104.32% (P < 0.001). 2 exhibited inhibitory activity against the release of beta-glucuronidase from the polymorphous nuclear leukocytes induced by PAF, with an inhibitory rate of 52.7% (P < 0.05) at the same concentration.
CONCLUSIONCompounds 1-17 were obtained from the genus Heteroplexis for the first time. 1 showed selective cytotoxic activity against human gastric cancer cell lines (BGC-823), 12 and 2 showed potent neuroprotective and anti-inflammatory activities, respectively.
Anti-HIV Agents ; chemistry ; pharmacology ; Anti-Inflammatory Agents ; chemistry ; pharmacology ; Asteraceae ; chemistry ; Cell Line ; Cell Survival ; drug effects ; Diterpenes ; chemistry ; pharmacology ; HIV-1 ; drug effects ; Humans ; Molecular Structure ; Nuclear Magnetic Resonance, Biomolecular ; Sesquiterpenes ; chemistry ; pharmacology ; Terpenes ; chemistry ; pharmacology
7.Increased Incidence of Severe Adverse Events in Non-Small Cell Lung Cancer Patients with Previous Tuberculosis Episode Treated with PD-1 Inhibitors
Zhang HUI ; Yuan JINFENG ; Xu YUANYUAN ; Yang MENGJIE ; Lyu JIALIN ; Yang XINJIE ; Sheng SHUYAN ; Qian ZHE ; Wang QUNHUI ; Pang YU ; Hu YING
Biomedical and Environmental Sciences 2024;37(7):785-789
Lung cancer is the top cause of cancer deaths globally.Advances in immune checkpoint inhibitors(ICIs)have transformed cancer treatment,but their use in lung cancer has led to more side effects.This study examined if past pulmonary tuberculosis(TB)affects ICIs'effectiveness and safety in lung cancer treatment.We reviewed lung cancer patients treated with ICIs at Beijing Chest Hospital from January 2019 to August 2022.We compared outcomes and side effects between patients with and without prior TB.Of 116 patients(40 with TB history,76 without),prior TB didn't reduce treatment effectiveness but did increase severe side effects.Notably,older patients(≥65 years)faced a higher risk of severe side effects.Detailed cases of two patients with severe side effects underscored TB as a risk factor in lung cancer patients receiving ICIs,stressing the need for careful monitoring and personalized care.
8.Experience and feelings of informal caregivers of patients with intracranial tumors: a systematic review
Jinfeng ZHU ; Lu CHEN ; Fang WANG ; Lixinbei SHENG ; Hengdan DI
Chinese Journal of Modern Nursing 2021;27(31):4256-4262
Objective:To systematically integrate the experience and feelings of informal caregivers of patients with intracranial tumors.Methods:Qualitative researches on the real experience and inner needs of informal family caregivers of patients with intracranial tumors were retrieved in the PubMed, Web of Science, China National Knowledge Infrastructure (CNKI) , WanFang Data, China Biomedical Database and VIP Chinese Journal Database by computer. The search time was from the establishment of the database to May 31, 2021. After screening and analysis, the critical appraisal tool for qualitative research (2017) of the Joanna Briggs Institute (JBI) Evidence-based Health Center in Australia were used to evaluate the articles and the results were Meta-integrated.Results:A total of 14 articles meeting the criteria were included. A total of 48 complete research themes were refined, and they were summarized and combined to form 3 comprehensive Meta-integration results and 4 new categories. The 3 Meta-integration results were that the caregiver experienced the shock, sadness, disbelief and hope in the early stage of diagnosis, and began to assume responsibility and learn to become a caregiver's psychological and emotional changes; the caregiver's family role and living environment changed, affecting the quality of life of caregivers; caregivers lacked information, care experience and social support.Conclusions:The quality of life of informal caregivers of patients with intracranial tumors and the changes in family functions have attracted attention. Social and medical workers should combine our country's cultural background to formulate effective intervention strategies and related health policies for the difficulties and challenges faced by this special population.
9.Value of MRI in the prediction of breast cancer with high expression of transcription factor E2F2
Ming ZHANG ; Lihua ZHANG ; Xiaoqing YU ; Jinfeng QIAN ; Meihong SHENG
Chinese Journal of Radiology 2024;58(5):510-516
Objective:To investigate the value of MRI in diagnosing the high expression of transcription factor E2F2 in breast cancer, in order to further evaluate the biological aggressiveness of breast cancer.Methods:The study was cross-sectional. The clinical and imaging data of 92 patients with breast cancer who were pathologically diagnosed in the Second Affiliated Hospital of Nantong University from October 2014 to December 2020 were retrospectively analyzed. All patients were female, aged 32 to 82 (56±11) years. All patients underwent MRI, including T 1WI, T 2WI, diffusion-weighted imaging (DWI), and dynamic enhanced MRI. According to the immunohistochemical results, the patients were divided into E2F2 high expression group and E2F2 low expression group. Independent sample t test, Mann-Whitney U test or χ2 test were used to compare the clinical data, MRI features and pathological features of the two groups. Characteristics with P≤0.1 from univariate analyses were included in multivariate logistic regression to screen for independent risk factors predicting high expression of the transcription factor E2F2 in breast cancer. Results:Among 92 patients, 68 were in the high E2F2 expression group and 24 were in the low E2F2 expression group. There were significant differences between the two groups in peritumoral edema, type composition ratio of time-signal intensity curve, estrogen receptor expression, human epidermal growth factor receptor 2 expression, endovascular cancer embolus and molecular type composition ratio (all P<0.05). Multivariate logistic regression analysis showed that peritumoral edema alone ( OR=7.061, 95% CI 1.837—27.144, P=0.004) was an independent risk factor for predicting the high expression of transcription factor E2F2 in breast cancer. Conclusion:MRI show that peritumoral edema is an independent risk factor for predicting high expression of the breast cancer transcription factor E2F2, which is associated with the aggressiveness of breast cancer.
10.Aromatic constituents of Heteroplexis micocephal and their bioactivities.
Xiaona FAN ; Sheng LIN ; Chenggen ZHU ; Yang LIU ; Jinfeng HU ; Xiaoguang CHEN ; Wenjie WANG ; Naihong CHEN ; Jiangong SHI
China Journal of Chinese Materia Medica 2011;36(1):48-56
OBJECTIVETo investigate the chemical constituents of Heteroplexis micocephal and their bioactivities.
METHODThe constituents were isolated by using a combination of various chromatographic techniques including column chromatography over macroporous adsorbent resin, silica gel, Pharmadex LH-20, and C-18, as well as reversed-phase HPLC. Structures of the isolates were identified by spectroscopic data analysis. In vitro cytotoxic, HIV-1 replication, neuroprotective, and anti-inflammatory activities were screened by using cell-based models.
RESULTThirty-one compounds were obtained. Twelve of them are phenylpropanols, and the structures were elucidated as (+)-(7S,8R)-guaiacylglycerol (1), ferulic acid (2), cinnamate methyl ester (3), 1-eicosanyl 3,4-dihydroxycinnamate (4), morinin B (5), sinapyl diangelate (6), chlorogenic acid (7), 4-O-caffeoylquinic acid (8), 5-O-caffeoylquinic acid (9), 5-O-caffeoylquinic acid methyl ester (10), 1,5-di-O-caffeoylquinic acid (11) and 4,5-di-O-caffeoylquinic acid methyl ester (12). Three lignans, (+)-pinoresinol (13), prinsepiol (14) and (+)-pinoresinol-O-beta-D-glucopyranoside (15). Four acetophenones, 2,4-diacetylanisole (16), espeleton (17), viscidone (18) and 12-hydroxytremetone-12-O-beta-D-glucopyranoside (19). Nine flavones, isosakuranetin (20), hesperetin (21), 3-methoxy-5,7,3',4'-tetrahydroxyflavone (22), acacetin (23), 5-hydroxy-7,4'- dimethoxyflavone (24), 7-methoxy-4',5, 6-trihydroxyflavone (25), 3,3'-dimethylquercetin (26), kaempferol 3-O-rutinoside (27), rutin (28). And three coumarins scopoletin (29), umbelliferone (30) and ayapin (31). Compound 6 and 22 showed selective cytotoxicities against a human stomach cancer cell line(BGC-823) and a human lung cancer cell line (A549) with IC50 values of 3.74 x 10(-5) and 7.17 x 10(-5) mol L(-1), respectively. In addition, Compound 6 showed a potent activity inhibiting HIV-1 replication with an IC50 value of 4.04 x 10(-6) mol L(-1), while 22 showed neuroprotective activity Against the MPP+ induced PC12-syn cell damage, with a relative protection ratio of 105.2% (P < 0.01) at a concentration of 10(-5) mol L(-1). Compound 26 and 31 showed inhibitory activities against the release of beta-glucuronidase of the polymorphous nuclear leukocytes induced by platelet activating factor (PAF), with inhibitory rates of 75.6% (P < 0.001) and 53. 9% (P < 0.01), respectively.
CONCLUSIONCompounds 1-31 were obtained from the genus Heteroplexis for the first time. Compound 6 and 22 possessed selective cytotoxicities against human cancer cell lines BGC-823 and A549, respectively. In addition, Compound 6 showed a potent activity inhibiting HIV-1 replication while 22 showed neuroprotective activity against the MPP+ induced PC12-syn cell damage. Compound 26 and 31 were potent anti-inflammatory agents.
Animals ; Antiviral Agents ; analysis ; pharmacology ; Cell Line, Tumor ; HIV-1 ; drug effects ; physiology ; Humans ; Myrtaceae ; chemistry ; Neurons ; cytology ; drug effects ; Neuroprotective Agents ; analysis ; pharmacology ; Plant Extracts ; analysis ; pharmacology ; Rats ; Virus Replication ; drug effects